Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1299, 2001-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
UK NICE issues COX-2 inhibitor guidance for OA, RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 324, 2001-01 ,pp. :
UK NICE issues guidance on pioglitazone for type 2 diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 304, 2001-01 ,pp. :
UK NICE issues guidance on pioglitazone for type 2 diabetes
Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. :
UK NICE issues rosiglitazone guidance for type 2 diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. :
UK NICE issues rosiglitazone guidance for type 2 diabetes
Inpharma, Vol. 1, Iss. 1252, 2000-01 ,pp. :